Full Press Release Details
NATICK, Mass. , Jan. 20, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) will webcast its conference call discussing financial results for the fourth quarter and full year ended December 31, 2011 on Thursday, February 2 , at 8:00 a.m. Eastern Time .
The call will be hosted by Hank Kucheman , Chief Executive Officer, Mike Mahoney , President, and Jeff Capello , Executive Vice President and Chief Financial Officer.
A live webcast of the conference call will be available via Boston Scientific's website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors . Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
The webcast is also being distributed over Thomson Financial's Investor Distribution Network via two locations: www.earnings.com , which is accessible to the public, and www.streetevents.com , a password-protected event management site.
An archived replay of the webcast will be accessible at www.bostonscientific.com/investors approximately one hour following the completion of the conference call and available for approximately one year.
The Company will issue a press release announcing financial results for the fourth quarter and full year 2011 on Thursday, February 2 , prior to the conference call.
About Boston Scientific Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com .
| CONTACT: | Denise Kaigler |
| 508-650-8330 (office) | |
| Media Relations | |
| Boston Scientific Corporation | |
| [email protected] | |
| Eric Olson | |
| 336-293-4393 (office) | |
| Media Relations | |
| Boston Scientific Corporation | |
| [email protected] | |
| Sean Wirtjes | |
| 508-652-5305 (office) | |
| Investor Relations | |
| Boston Scientific Corporation | |
| [email protected] |
SOURCE Boston Scientific Corporation